{
  "id": "602c192c1cb411341a000119",
  "type": "summary",
  "question": "What is AZD8601?",
  "ideal_answer": "AZD8601 is a modified mRNA encoding vascular endothelial growth factor A (VEGF-A). Sequential dosing of AZD8601 improves vascularization and tissue oxygenation of the wound bed, leading to accelerated re-epithelialization during the early phase of diabetic wound healing.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/30504800"
  ],
  "snippets": [
    {
      "text": "Here, we longitudinally and comprehensively characterize microvascular responses to AZD8601, a modified mRNA encoding vascular endothelial growth factor A (VEGF-A), in vivo. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30504800",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using a boron nanoparticle-based tissue oxygen sensor, we show that sequential dosing of AZD8601 improves vascularization and tissue oxygenation of the wound bed, leading to accelerated re-epithelialization during the early phase of diabetic wound healing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30504800",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}